1. Home
  2. VSTM vs DSM Comparison

VSTM vs DSM Comparison

Compare VSTM & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • DSM
  • Stock Information
  • Founded
  • VSTM 2010
  • DSM 1989
  • Country
  • VSTM United States
  • DSM United States
  • Employees
  • VSTM N/A
  • DSM N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • DSM Investment Managers
  • Sector
  • VSTM Health Care
  • DSM Finance
  • Exchange
  • VSTM Nasdaq
  • DSM Nasdaq
  • Market Cap
  • VSTM 345.6M
  • DSM 280.8M
  • IPO Year
  • VSTM 2012
  • DSM N/A
  • Fundamental
  • Price
  • VSTM $8.23
  • DSM $5.61
  • Analyst Decision
  • VSTM Strong Buy
  • DSM
  • Analyst Count
  • VSTM 9
  • DSM 0
  • Target Price
  • VSTM $12.75
  • DSM N/A
  • AVG Volume (30 Days)
  • VSTM 3.1M
  • DSM 161.7K
  • Earning Date
  • VSTM 08-07-2025
  • DSM 01-01-0001
  • Dividend Yield
  • VSTM N/A
  • DSM 3.97%
  • EPS Growth
  • VSTM N/A
  • DSM N/A
  • EPS
  • VSTM N/A
  • DSM N/A
  • Revenue
  • VSTM $2,137,000.00
  • DSM N/A
  • Revenue This Year
  • VSTM $55.63
  • DSM N/A
  • Revenue Next Year
  • VSTM $453.72
  • DSM N/A
  • P/E Ratio
  • VSTM N/A
  • DSM N/A
  • Revenue Growth
  • VSTM N/A
  • DSM N/A
  • 52 Week Low
  • VSTM $2.24
  • DSM $4.69
  • 52 Week High
  • VSTM $9.10
  • DSM $6.05
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 73.06
  • DSM 53.52
  • Support Level
  • VSTM $7.44
  • DSM $5.58
  • Resistance Level
  • VSTM $8.76
  • DSM $5.70
  • Average True Range (ATR)
  • VSTM 0.64
  • DSM 0.06
  • MACD
  • VSTM 0.23
  • DSM 0.01
  • Stochastic Oscillator
  • VSTM 84.05
  • DSM 60.42

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About DSM BNY Mellon Strategic Municipal Bond Fund Inc.

BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.

Share on Social Networks: